995 related articles for article (PubMed ID: 18844109)
1. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
[TBL] [Abstract][Full Text] [Related]
2. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients.
Ren T; Wen ZK; Liu ZM; Qian C; Liang YJ; Jin ML; Cai YY; Xu L
Cancer Invest; 2008 Jun; 26(5):448-55. PubMed ID: 18568766
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory effect and molecular mechanism of deoxyribonucleic acid receptor toll-like receptor 9 signaling pathway on newborn babies with acute lung injury.
Dou L; Chai Y; Shi H
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(15):99-102. PubMed ID: 38279483
[TBL] [Abstract][Full Text] [Related]
4. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil].
Chi PD; Li L; Fan YY; Wu CY
Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537
[TBL] [Abstract][Full Text] [Related]
5. The immunostimulatory effect of CpG oligodeoxynucleotides on peripheral blood mononuclear cells of healthy dogs and dogs with atopic dermatitis.
Jassies-van der Lee A; Rutten V; Spiering R; van Kooten P; Willemse T; Broere F
Vet J; 2014 Apr; 200(1):103-8. PubMed ID: 24461202
[TBL] [Abstract][Full Text] [Related]
6. [Toll-like receptor 9 in cpG oligodeoxynucleotides-induced species-specific immune responses].
Li N; Fan XG; Tang SE; Zhu C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):533-5. PubMed ID: 16320582
[TBL] [Abstract][Full Text] [Related]
7. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.
Offersen R; Nissen SK; Rasmussen TA; Østergaard L; Denton PW; Søgaard OS; Tolstrup M
J Virol; 2016 May; 90(9):4441-4453. PubMed ID: 26889036
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of TLR9 expression on PBMCs and CpG ODN-TLR9 ligation on IFN-α production in SLE patients.
Mortezagholi S; Babaloo Z; Rahimzadeh P; Namdari H; Ghaedi M; Gharibdoost F; Mirzaei R; Bidad K; Salehi E
Immunopharmacol Immunotoxicol; 2017 Feb; 39(1):11-18. PubMed ID: 28049380
[TBL] [Abstract][Full Text] [Related]
9. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
Merlo A; Calcaterra C; Mènard S; Balsari A
J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
[TBL] [Abstract][Full Text] [Related]
10. Guanine-modified inhibitory oligonucleotides efficiently impair TLR7- and TLR9-mediated immune responses of human immune cells.
Römmler F; Hammel M; Waldhuber A; Müller T; Jurk M; Uhlmann E; Wagner H; Vollmer J; Miethke T
PLoS One; 2015; 10(2):e0116703. PubMed ID: 25695778
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
Abu-Rish EY; Amrani Y; Browning MJ
Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
[TBL] [Abstract][Full Text] [Related]
12. [Activation ability of CpG ODNs 2216 on PBMNCs from leukemia patients in remission and killing effect of activated PBMNCs on K562 cells].
Gu YY; Chen JH; Ouyang J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):874-8. PubMed ID: 19698220
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory effects of atorvastatin on peripheral blood mononuclear cells and synovial fibroblasts in rheumatoid arthritis.
Blaschke S; Viereck V; Schwarz G; Klinger HM; Guerluek S; Müller GA
Scand J Rheumatol; 2009; 38(4):235-9. PubMed ID: 19247848
[TBL] [Abstract][Full Text] [Related]
14. Expression of Toll-like receptor9 in diffuse large B-cell lymphoma: further exploring CpG oligodeoxynucleotide in NFκB pathway.
Huang WT; Weng SW; Huang CC; Lin HC; Tsai PC; Chuang JH
APMIS; 2012 Nov; 120(11):872-81. PubMed ID: 23009111
[TBL] [Abstract][Full Text] [Related]
15. CpG-oligodeoxynucleotides enhance T-cell receptor-triggered interferon-gamma production and up-regulation of CD69 via induction of antigen-presenting cell-derived interferon type I and interleukin-12.
Kranzer K; Bauer M; Lipford GB; Heeg K; Wagner H; Lang R
Immunology; 2000 Feb; 99(2):170-8. PubMed ID: 10692033
[TBL] [Abstract][Full Text] [Related]
16. Innate immune responses induced by classes of CpG oligodeoxynucleotides in ovine lymph node and blood mononuclear cells.
Booth JS; Nichani AK; Benjamin P; Dar A; Krieg AM; Babiuk LA; Mutwiri GK
Vet Immunol Immunopathol; 2007 Jan; 115(1-2):24-34. PubMed ID: 17067685
[TBL] [Abstract][Full Text] [Related]
17. Direct Engagement of TLR9 Ligand with T Helper Cells Leads to Cell Proliferation & Up-regulation of Cytokines.
Sharma RK; Sehgal S; Sachdeva N; Kumar R; Gupta A
Immunol Invest; 2019 Jan; 48(1):79-95. PubMed ID: 30239236
[TBL] [Abstract][Full Text] [Related]
18. C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level.
Jurk M; Schulte B; Kritzler A; Noll B; Uhlmann E; Wader T; Schetter C; Krieg AM; Vollmer J
Immunobiology; 2004; 209(1-2):141-54. PubMed ID: 15481148
[TBL] [Abstract][Full Text] [Related]
19. Deoxycytidyl-deoxyguanosine oligonucleotide classes A, B, and C induce distinct cytokine gene expression patterns in rhesus monkey peripheral blood mononuclear cells and distinct alpha interferon responses in TLR9-expressing rhesus monkey plasmacytoid dendritic cells.
Abel K; Wang Y; Fritts L; Sanchez E; Chung E; Fitzgerald-Bocarsly P; Krieg AM; Miller CJ
Clin Diagn Lab Immunol; 2005 May; 12(5):606-21. PubMed ID: 15879022
[TBL] [Abstract][Full Text] [Related]
20. Anti-HBV effects of CpG oligodeoxynucleotide-activated peripheral blood mononuclear cells from patients with chronic hepatitis B.
Li N; Fan XG; Chen ZH; Huang Y; Quan J; Liu ZB
APMIS; 2005 Oct; 113(10):647-54. PubMed ID: 16309422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]